Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia

PJ Laitinen, KM Brown, K Piippo, H Swan… - Circulation, 2001 - Am Heart Assoc
Background—Familial polymorphic ventricular tachycardia is an autosomal-dominant,
inherited disease with a relatively early onset and a mortality rate of≈ 30% by the age of 30 …

Arrhythmic disorder mapped to chromosome 1q42–q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts

H Swan, K Piippo, M Viitasalo, P Heikkilä… - Journal of the American …, 1999 - jacc.org
OBJECTIVES The purpose of this study was to provide clinical and anatomical
characteristics as well as genetic background of a malignant arrhythmogenic disorder …

Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights

K Kontula, PJ Laitinen, A Lehtonen… - Cardiovascular …, 2005 - academic.oup.com
Cardiac excitation–contraction coupling occurs by a calcium ion-mediated mechanism in
which the signal of action potential is converted into Ca2+ influx into the cardiomyocytes …

Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak

SE Lehnart, XHT Wehrens, PJ Laitinen, SR Reiken… - Circulation, 2004 - Am Heart Assoc
Background—Familial polymorphic ventricular tachycardia (FPVT) is characterized by
exercise-induced arrhythmias and sudden cardiac death due to missense mutations in the …

Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture

AL Lahti, VJ Kujala, H Chapman… - Disease models & …, 2012 - journals.biologists.com
Long QT syndrome (LQTS) is caused by functional alterations in cardiac ion channels and is
associated with prolonged cardiac repolarization time and increased risk of ventricular …

High prevalence of four long QT syndrome founder mutations in the Finnish population

A Marjamaa, V Salomaa, C Newton-Cheh… - Annals of …, 2009 - Taylor & Francis
Aims. Long QT syndrome (LQTS) is an inherited arrhythmia disorder with an estimated
prevalence of 0.01%–0.05%. In Finland, four founder mutations constitute up to 70% of the …

High efficacy of β-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of β-blocker treatment “failures”

GM Vincent, PJ Schwartz, I Denjoy, H Swan, C Bithell… - Circulation, 2009 - Am Heart Assoc
Background—β-Blocker efficacy in long-QT syndrome type 1 is good but variably reported,
and the causes of cardiac events despite β-blocker therapy have not been ascertained …

Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects

H Swan, M Viitasalo, K Piippo, P Laitinen… - Journal of the American …, 1999 - jacc.org
OBJECTIVES This study was performed to evaluate the QT interval and heart rate responses
to exercise and recovery in gene and mutation type-specific subgroups of long QT syndrome …

The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a …

L Crotti, C Spazzolini, PJ Schwartz, W Shimizu… - Circulation, 2007 - Am Heart Assoc
Background—The impressive clinical heterogeneity of the long-QT syndrome (LQTS)
remains partially unexplained. In a South African (SA) founder population, we identified a …

[HTML][HTML] Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations

K Kujala, J Paavola, A Lahti, K Larsson… - 2012 - journals.plos.org
Background Induced pluripotent stem cells (iPSC) provide means to study the
pathophysiology of genetic disorders. Catecholaminergic polymorphic ventricular …